Blog Read the latest perspectives from our team of subject matter experts and others Bridging the Feasibility Gap: A Smarter Path to Clinical Trial EnrollmentDespite decades of progress in data access and analytics, the clinical research industry continues to struggle with one seemingly simple challenge: enrolling patients on time. The statistics are stark: nearly… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact KOL Engagement Patient Representation Provider Data Post Industries:Digital Health Health Plans Pharmaceutical & Biotechnology KOL EngagementBoost HCP Access with a Unified Healthcare Data PlatformIn an August 2022 market research study conducted by H1 and the Medical Science Liaison Society (MSLS), more than 600 MSLs surveyed weighed in on their experiences and preferences… Continue reading → Read the articleno Artificial IntelligenceDrug Development4 AI predictions for the Life Sciences Sector by 2025The application of AI in the life sciences sector has the potential to revolutionize many aspects of research, development, and patient care. By 2025, we can anticipate pretty significant shifts… Continue reading → Read the articleno KOL EngagementKOL to Go? The Modern MSL & Mobile AppsAs the pharmaceutical industry becomes increasingly competitive, speed and efficiency are crucial for getting drugs to market faster. This is where mobile apps come in. And at the heart of… Continue reading → Read the articleno KOL EngagementFrom Academia to Patients: The Evolution of MSL TerritoriesAs the role of the Medical Science Liaison (MSL) has evolved from academic rigor to understanding disease trends, a key component of MSL territory planning is collaboration with Key… Continue reading → Read the articleno Artificial IntelligenceCommercializationDrug DevelopmentPatient Representation7 Ways of Generating AI-produced ROI for Life SciencesFor life sciences companies, the application of AI has the potential to provide transformative value, not only in terms of direct financial return but also through operational, research, and clinical… Continue reading → Read the articleno Drug DevelopmentPatient RepresentationThe Trust Fall: Building Successful Trials Outside the U.S.As the U.S. ramps up for release of the latest COVID-19 vaccine booster, the Centers for Disease Control and Prevention (CDC) recommends that all Americans aged 6 months and… Continue reading → Read the articleno‹1234567›»
